• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Raysearch Laboratories

222.20 SEK

+4.12 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.12 %
+25.75 %
+16.95 %
-2.54 %
-4.02 %
-31.31 %
+222.50 %
+136.13 %
+298.38 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Read more
Market cap
7.62B SEK
Turnover
29.23M SEK
Revenue
1.34B
EBIT %
21.74 %
P/E
33.41
Dividend yield-%
1.8 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.8
2026

Interim report Q2'26

3.11
2026

Interim report Q3'26

10.2
2027

Annual report '26

Press release6/5/2026, 7:35 AM

RaySearch to showcase new advances in particle therapy at PTCOG 64

Raysearch Laboratories
Press release5/21/2026, 11:38 AM

Antony Lomax joins RaySearch to strengthen leadership in particle therapy

Raysearch Laboratories
Press release5/18/2026, 7:06 AM

First patients treated with RayCare at Raigmore Hospital

Raysearch Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/13/2026, 3:30 PM

RaySearch to showcase groundbreaking innovations at ESTRO 2026

Raysearch Laboratories
Press release5/12/2026, 8:05 AM

First online adaptive treatment on TrueBeam using RayStation and RayCare

Raysearch Laboratories
Regulatory press release5/7/2026, 6:10 PM

Bulletin from the Annual General Meeting 2026

Raysearch Laboratories
Regulatory press release4/29/2026, 5:30 AM

Interim report first quarter 2026: Strong long-term performance and raised margin target

Raysearch Laboratories
Press release4/27/2026, 8:20 AM

Institut Hartmann selects RayStation and RayCare

Raysearch Laboratories
Press release4/22/2026, 9:10 AM

Invitation to presentation of RaySearch’s interim report for the first quarter of 2026

Raysearch Laboratories
Regulatory press release4/19/2026, 5:45 PM

Günther Mårder resigns from the Board of RaySearch

Raysearch Laboratories
Press release4/17/2026, 6:45 AM

RaySearch receives first RayCare order in China

Raysearch Laboratories
Regulatory press release4/15/2026, 2:15 PM

RaySearch publishes Annual Report for 2025

Raysearch Laboratories
Regulatory press release4/2/2026, 8:00 AM

Notice of Annual General Meeting 2026

Raysearch Laboratories
Press release3/19/2026, 9:05 AM

First patient treated in Ukraine using RayStation

Raysearch Laboratories
Press release2/16/2026, 9:52 AM

Redeye: RaySearch Laboratories (Q4 Review): A beaming end it was

Raysearch Laboratories
Regulatory press release2/12/2026, 6:30 AM

Year-end report 2025: Record revenue and strong earnings growth despite currency headwinds

Raysearch Laboratories
Press release2/4/2026, 1:30 PM

The Royal Marsden NHS Foundation Trust uses RayStation for online adaptive treatments with conventional C-arm linacs

Raysearch Laboratories
Press release1/28/2026, 12:35 PM

Invitation to presentation of RaySearch’s interim report for the fourth quarter of 2025

Raysearch Laboratories
Regulatory press release12/30/2025, 9:00 AM

New number of votes in RaySearch Laboratories AB due to conversion

Raysearch Laboratories
Press release12/18/2025, 1:15 PM

Jenna Styan joins RaySearch as Director of Corporate Strategy

Raysearch Laboratories